ProfileGDS5822 / ILMN_1215651
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 63% 6% 61% 51% 10% 10% 38% 28% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 132.363
GSM1276600PDAC Late Ablation Control 2106
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 127.261
GSM1276603PDAC Late Ablation 223.651
GSM1276604PDAC Late Ablation 38.210
GSM1303940PDAC Late Ablation_anti-CTLA4 19.710
GSM1303941PDAC Late Ablation_anti-CTLA4 218.438
GSM1303942PDAC Late Ablation_anti-CTLA4 313.928